21
Participants
Start Date
January 4, 2020
Primary Completion Date
March 29, 2022
Study Completion Date
May 9, 2022
fosmanogepix
IV and oral fosmanogepix
Cliniques Universitaires de Bruxelles Hôpital Erasme - Department of Infectious Diseases, Brussels
UZ Leuven - Department of Haematology, Leuven
CHU UCL Namur - Mont- Godinne University Hospital - Intensive Care Unit, Yvoir
Duke Department of Pharmacy/Investigational Drug Service (IDS), Durham
Duke Medicine Pavilion, Durham
Duke University Medical Center (Duke South Clinic), Durham
Duke University Medical Center(Duke Hospital), Durham
Universitätsmedizin der Johannes Gutenberg-Universität Mainz III, Mainz
Klinikum Neuperlach, Klinik fur Hamatologie und Onkologie, München
City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
IP Address : City of Hope Investigational Drug Services (IDS), Duarte
Pharmacy, Haifa
Rambam Medical Center, Haifa
Pharmacy, Ramat Gan
Sheba Medical Center, Tel Hashomer, Ramat Gan
Lead Sponsor
Basilea Pharmaceutica
INDUSTRY